Low-dose LBH589 increases the sensitivity of cisplatin to cisplatin-resistant ovarian cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Low-dose LBH589 increases the sensitivity of cisplatin to cisplatin-resistant ovarian cancer cells

Published:2011-06 Issue:2 Volume:50 Page:165-171
ISSN:1028-4559
Container-title:Taiwanese Journal of Obstetrics and Gynecology
language:en
Short-container-title:Taiwanese Journal of Obstetrics and Gynecology

Author:

Ma Yen-Ying,Lin Hao,Moh Jau-Sung,Chen Kuang-Den,Wang I-Wen,Ou Yu-Che,You Ying-Shu,Lung Chia-Chi

Funder

Chang Gung Memorial Hospital at Kaohsiung

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference34 articles.

1. Management of relapsed/refractory epithelial ovarian cancer: current standards and novel approaches;Lin;Taiwan J Obstet Gynecol,2007

2. Ovarian cancer: strategies for overcoming resistance to chemotherapy;Agarwal;Nat Rev Cancer,2003

3. Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetate;Isonishi;J Biol Chem,1990

4. Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells;Isonishi;Br J Cancer,2000

5. Valproic acid resensitizes cisplatin-resistant ovarian cancer cells;Lin;Cancer Sci,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities;Cancers;2023-01-10

2. Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain;Cancers;2022-12-08

3. Potential of histone deacetylase inhibitors for the therapy of ovarian cancer;Frontiers in Oncology;2022-11-25

4. Tackling drug resistance in ovarian cancer with epigenetic targeted drugs;European Journal of Pharmacology;2022-07

5. A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer;Cancers;2021-07-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3